Tear proteomics in keratoconus

Molecular Vision

Volumn 16, Issue , 2010, Pages 1949-1957

  Pannebaker, Catherine ^a   Chandler, Heather L ^a   Nichols, Jason J ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD79A ANTIGEN; DEATH RECEPTOR 4; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR 4; FIBROBLAST GROWTH FACTOR 6; FIBROBLAST GROWTH FACTOR 9; GELATINASE A; GELATINASE B; HORMONE PRECURSOR; IMMUNOGLOBULIN KAPPA CHAIN; INTERLEUKIN 11; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR BETA; INTERLEUKIN 2 RECEPTOR GAMMA; INTERLEUKIN 6; INTERLEUKIN 8; INTERLEUKIN 9; INTERSTITIAL COLLAGENASE; KERATIN; LIPOCALIN; LYSOZYME; LYSOZYME C; PROPROLACTIN; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UNCLASSIFIED DRUG;

ADULT; ANAMNESIS; ARTICLE; CLINICAL ARTICLE; CONTACT LENS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GAS PERMEABILITY; HUMAN; KERATOCONUS; KERATOMETRY; MALE; MASS SPECTROMETRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; SLIT LAMP; TEAR FILM; VISUAL ACUITY;

ADULT; ANTIBODIES; BIOLOGICAL ASSAY; CONTACT LENSES; CYTOKINES; DENSITOMETRY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EYE PROTEINS; FEMALE; HUMANS; KERATOCONUS; MALE; MASS SPECTROMETRY; MIDDLE AGED; PROTEIN ARRAY ANALYSIS; PROTEOMICS; TEARS;

EID: 78149484556     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Rabinowitz YS. Keratoconus. Surv Ophthalmol 1998; 42:297-319.
2. E. Bennett BW. Advanced Contact Lens Application. Clinical contact lens practice. Philadelphia, PA: Lippincott Williams & Wilkins; 2005. p. 568-70.
3. Cristina Kenney M, Brown DJ. The cascade hypothesis of keratoconus. Cont Lens Anterior Eye 2003; 26:139-46.
4. Lema I, Duran JA. Inflammatory molecules in the tears of patients with keratoconus. Ophthalmology 2005; 112:654-9.
5. Rabinowitz Y, ed. 1st Annual Global Keratoconus Congress; 2007 January 27, 2007; Las Vegas, Nevada.
6. Zadnik K, Barr JT, Edrington TB, Everett DF, Jameson M, McMahon TT, Shin JA, Sterling JL, Wagner H, Gordon MO. Baseline findings in the Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study. Invest Ophthalmol Vis Sci 1998; 39:2537-46.
7. Catania L. Primary Care of the Anterior Segment, Second Edition. East Norwalk: Appleton & Lange; 1995. p. 266.
8. Riordan-Eva P. Vaughan and Asbury's General Ophthalmology. McGraw-Hill Professional; 2004. p. 144.
9. de Souza GA, Godoy LM, Mann M. Identification of 491 proteins in the tear fluid proteome reveals a large number of proteases and protease inhibitors. Genome Biol 2006; 7:R72.
10. Kijlstra A, Kuizenga A. Analysis and function of the human tear proteins. Adv Exp Med Biol 1994; 350:299-308.
11. McMahon TT, Szczotka-Flynn L, Barr JT, Anderson RJ, Slaughter ME, Lass JH, Iyengar SK. A new method for grading the severity of keratoconus: the Keratoconus Severity Score (KSS). Cornea 2006; 25:794-800.
12. Carr S, Aebersold R, Baldwin M, Burlingame A, Clauser K, Nesvizhskii A. The need for guidelines in publication of peptide and protein identification data: Working Group on Publication Guidelines for Peptide and Protein Identification Data. Mol Cell Proteomics 2004; 3:531-3.
13. Baldwin MA. Protein identification by mass spectrometry: issues to be considered. Mol Cell Proteomics 2004; 3:1-9.
14. Kemp EG, Lewis CJ. Immunoglobulin patterns in keratoconus with particular reference to total and specific IgE levels. Br J Ophthalmol 1982; 66:717-20.
15. Rahi A, Davies P, Ruben M, Lobascher D, Menon J. Keratoconus and coexisting atopic disease. Br J Ophthalmol 1977; 61:761-4.
16. Li DQ, Pflugfelder SC. Matrix metalloproteinases in corneal inflammation. Ocul Surf 2005; 3:S198-202.
17. Collier SA. Is the corneal degradation in keratoconus caused by matrix-metalloproteinases? Clin Experiment Ophthalmol 2001; 29:340-4.
18. Fini ME, Yue BY, Sugar J. Collagenolytic/gelatinolytic metalloproteinases in normal and keratoconus corneas. Curr Eye Res 1992; 11:849-62.
19. Kenney MC, Chwa M, Alba A, Saghizadeh M, Huang ZS, Brown DJ. Localization of TIMP-1, TIMP-2, TIMP-3, gelatinase A and gelatinase B in pathological human corneas. Curr Eye Res 1998; 17:238-46.
20. Zhou L, Sawaguchi S, Twining SS, Sugar J, Feder RS, Yue BY. Expression of degradative enzymes and protease inhibitors in corneas with keratoconus. Invest Ophthalmol Vis Sci 1998; 39:1117-24.
21. Fabre EJ, Bureau J, Pouliquen Y, Lorans G. Binding sites for human interleukin 1 alpha, gamma interferon and tumor necrosis factor on cultured fibroblasts of normal cornea and keratoconus. Curr Eye Res 1991; 10:585-92.
22. Abalain JH, Dossou H, Colin J, Floch HH. Levels of collagen degradation products (telopeptides) in the tear film of patients with keratoconus. Cornea 2000; 19:474-6.
23. Gondhowiardjo TD, van Haeringen NJ. Corneal aldehyde dehydrogenase, glutathione reductase, and glutathione Stransferase in pathologic corneas. Cornea 1993; 12:310-4.
24. Brown DJ, Lin B, Chwa M, Atilano SR, Kim DW, Kenney MC. Elements of the nitric oxide pathway can degrade TIMP-1 and increase gelatinase activity. Mol Vis 2004; 10:281-8.
25. Sawaguchi S, Twining SS, Yue BY, Wilson PM, Sugar J, Chan SK. Alpha-1 proteinase inhibitor levels in keratoconus. Exp Eye Res 1990; 50:549-54.
26. Saika S, Yamanaka O, Sumioka T, Miyamoto T, Miyazaki K, Okada Y, Kitano A, Shirai K, Tanaka S, Ikeda K. Fibrotic disorders in the eye: targets of gene therapy. Prog Retin Eye Res 2008; 27:177-96.
27. Fini ME, Stramer BM. How the cornea heals: cornea-specific repair mechanisms affecting surgical outcomes. Cornea 2005; 24:S2-11.
28. Shoshani Y, Pe'er J, Doviner V, Frucht-Pery J, Solomon A. Increased expression of inflammatory cytokines and matrix metalloproteinases in pseudophakic corneal edema. Invest Ophthalmol Vis Sci 2005; 46:1940-7.
29. Seppälä HP, Maatta M, Rautia M, Mackiewicz Z, Tuisku I, Tervo T, Konttinen YT. EMMPRIN and MMP-1 in keratoconus. Cornea 2006; 25:325-30.
30. Matthews FJ, Cook SD, Majid MA, Dick AD, Smith VA. Changes in the balance of the tissue inhibitor of matrix metalloproteinases (TIMPs)-1 and -3 may promote keratocyte apoptosis in keratoconus. Exp Eye Res 2007; 84:1125-34.
31. Kenney MC, Chwa M, Atilano SR, Tran A, Carballo M, Saghizadeh M, Vasiliou V, Adachi W, Brown DJ. Increased levels of catalase and cathepsin V/L2 but decreased TIMP-1 in keratoconus corneas: evidence that oxidative stress plays a role in this disorder. Invest Ophthalmol Vis Sci 2005; 46:823-32.
32. Smith VA, Matthews FJ, Majid MA, Cook SD. Keratoconus: matrix metalloproteinase-2 activation and TIMP modulation. Biochim Biophys Acta 2006; 1762:431-9.
33. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, Sutherland GR, Smith TD, Rauch C, Smith CA. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 1995; 3:673-82.
34. Bouralexis S, Findlay DM, Evdokiou A. Death to the bad guys: targeting cancer via Apo2L/TRAIL. Apoptosis 2005; 10:35-51.
35. Van Geelen CM, de Vries EG, de Jong S. Lessons from TRAILresistance mechanisms in colorectal cancer cells: paving the road to patient-tailored therapy. Drug Resist Updat 2004; 7:345-58.
36. Pukac L, Kanakara P, Humphreys R, Alderson R, Bloom M, Sung C, Riccobene T, Johnson R, Fiscella M, Mahoney A, Carrell J, Boyd E, Yao XT, Zhang L, Zhong L, von Kerczek A, Shepard L, Vaughan T, Edwards B, Dobson C, Salcedo T, Albert V. HGS-ETR1, a fully human TRAIL-receptor 1 monoclonal antibody, induces cell death in multiple tumour types in vitro and in vivo. Br J Cancer 2005; 92:1430-41.
37. Nakamura T, Nishida K, Dota A, Matsuki M, Yamanishi K, Kinoshita S. Elevated expression of transglutaminase 1 and keratinization-related proteins in conjunctiva in severe ocular surface disease. Invest Ophthalmol Vis Sci 2001; 42:549-56.
38. Nakamura T. Molecular mechanism of pathological keratinization in severe ocular surface diseases. Nippon Ganka Gakkai Zasshi 2004; 108:654-64.
39. Dogru M, Karakaya H, Ozcetin H, Erturk H, Yucel A, Ozmen A, Baykara M, Tsubota K. Tear function and ocular surface changes in keratoconus. Ophthalmology 2003; 110:1110-8.
40. Aihara T, Fujiwara Y, Miyake Y, Okami J, Okada Y, Iwao K, Sugita Y, Tomita N, Sakon M, Shiozaki H, Monden M. Mammaglobin B gene as a novel marker for lymph node micrometastasis in patients with abdominal cancers. Cancer Lett 2000; 150:79-84.
41. Molloy MP, Bolis S, Herbert BR, Ou K, Tyler MI, van Dyk DD, Willcox MD, Gooley AA, Williams KL, Morris CA, Walsh BJ. Establishment of the human reflex tear two-dimensional polyacrylamide gel electrophoresis reference map: new proteins of potential diagnostic value. Electrophoresis 1997; 18:2811-5.
42. Evans V, Vockler C, Friedlander M, Walsh B, Willcox MD. Lacryglobin in human tears, a potential marker for cancer. Clin Experiment Ophthalmol 2001; 29:161-3.
43. Stoeckelhuber M, Messmer EM, Schmidt C, Xiao F, Schubert C, Klug J. Immunohistochemical analysis of secretoglobin SCGB 2A1 expression in human ocular glands and tissues. Histochem Cell Biol 2006; 126:103-9.